| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 84,106 | 85,496 | 84,290 | 102,892 | | Cost of Revenue | 38,756 | 38,741 | 39,614 | 71,309 | | | Gross Profit | 45,350 | 46,755 | 44,676 | 31,583 | | | Operating Expenses | | Research Development | 1,585 | (165) | 165 |
-
| | Selling General and Administrative | 2,588 | 6,011 | 4,383 | (18,466) | | Non Recurring | 1,128 | 563 | 1,548 | 117,578 | | Others | 28,934 | 29,474 | 28,658 | 34,399 | | | | Total Operating Expenses | 34,235 | 35,883 | 34,754 |
-
| | | | Operating Income or Loss | 11,115 | 10,872 | 9,922 | (101,928) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 10,537 | 16,542 | 29,937 | (6,719) | | Earnings Before Interest And Taxes | 22,578 | 26,566 | 42,299 | (95,130) | | Interest Expense | 23,839 | 23,618 | 21,735 | 19,129 | | Income Before Tax | (1,261) | 2,948 | 20,564 | (114,259) | | Income Tax Expense | 352 | 220 | (3,090) | (236) | | Minority Interest | (7,345) | 4,885 | (4,885) | 18,226 | | | | Net Income From Continuing Ops | (1,261) | 2,948 | 20,564 | (96,798) | | | Non-recurring Events | | Discontinued Operations | 858 | (1,324) | 274 | (6,990) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (7,748) | 6,509 | 15,953 | (103,788) | | Preferred Stock And Other Adjustments | 4,378 | (8,383) | (2,078) | (2,068) | | | Net Income Applicable To Common Shares | ($3,370) | ($1,874) | $13,875 | ($105,856) |
|
0.25% Nasdaq 
0.01%
Income Statement
